FSLY Form 144 Files Planned Sale of 178,931 Shares via Morgan Stanley
Rhea-AI Filing Summary
Form 144 notice for Fastly, Inc. (FSLY) shows a proposed sale of 178,931 common shares held as restricted stock units, with an aggregate market value of $1,383,136.63, to be sold on or about 09/15/2025 through Morgan Stanley Smith Barney LLC on the NYSE. The RSUs were acquired from the issuer on 06/15/2025 and reported as vested/issued the same day. The filer previously reported three sales of common shares in the past three months totaling 135,303 shares for gross proceeds of $977,929.03 across dates 06/17/2025, 08/18/2025, and 09/03/2025. The filer attests they do not possess undisclosed material adverse information about the issuer.
Positive
- Full disclosure of planned sale including acquisition date, number of shares, broker, and intended sale date
- Prior sales in the past three months are reported, showing transparency and compliance with Rule 144 aggregation requirements
Negative
- None.
Insights
TL;DR: Insider plans to sell 178,931 RSU-derived shares valued at $1.38M; notable recent insider sales totaled $977.9K.
This Form 144 documents a planned sale of restricted stock units converted to common shares, indicating the filer intends to liquidate equity received on 06/15/2025. The transactions are to be executed through Morgan Stanley Smith Barney LLC on the NYSE and mirror prior dispositions in June, August, and September 2025. For investors, these are routine insider liquidity events rather than explicit commentary on company fundamentals; the filing contains no statements about company performance or undisclosed material information.
TL;DR: Filing is a standard Rule 144 disclosure of RSU-derived share sales with prior recent sales disclosed.
The form properly discloses the nature and timing of acquisition (Restricted Stock Units, 06/15/2025), planned sale size, broker, and exchange. It also lists prior sales in the past three months, providing transparency required under Rule 144. No information in the filing suggests regulatory, governance, or compliance concerns; the signer affirms lack of undisclosed material information as required.